Video Head Impulse Test and Seasickness Susceptibility
NCT05657340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86
Last updated 2022-12-20
Summary
This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score.
All subjects from both groups underwent video head impulse testing (vHIT). VHIT parameters - gain, asymmetry ect were compared between both groups.
Conditions
- Sea Sickness
Interventions
- DIAGNOSTIC_TEST
-
Video-head impulse testing
Video-head impulse testing is a recent diagnostic bed-side test for evaluation of semi-circular canal function.
Sponsors & Collaborators
-
Medical Corps, Israel Defense Force
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2020-05-01
- Completion
- 2020-05-01
Countries
- Israel
Study Locations
More Related Trials
-
Meclizine Plasma Levels in Responders and Non-responders
NCT04482985 ·Status: UNKNOWN ·Phase: PHASE4
-
Motion Sickness on Astrolabe's Vessel
NCT02911402 ·Status: COMPLETED
-
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
NCT03988530 ·Status: COMPLETED ·Phase: PHASE3
-
The Prevention and Treatment of Nausea Associated With Motion Sickness
NCT03986905 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
NCT03755596 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Cortical Excitability in Cyclic Vomiting Syndrome
NCT05256160 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT05548270 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
NCT04184115 ·Status: COMPLETED ·Phase: PHASE3
-
Noninvasive Markers of Functional Nausea in Children
NCT03593811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
NCT05852730 ·Status: RECRUITING ·Phase: PHASE2
-
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
NCT05611814 ·Status: COMPLETED ·Phase: NA
-
Phase I Norovirus Challenge Model
NCT04174560 ·Status: COMPLETED ·Phase: PHASE1
-
Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media
NCT03019341 ·Status: COMPLETED
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
NCT04327661 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
NCT03920644 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients
NCT03560583 ·Status: RECRUITING ·Phase: NA
-
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
NCT00332137 ·Status: COMPLETED ·Phase: PHASE2
-
Visual Distraction as a Means of Enhancing Child Resistance
NCT01859780 ·Status: COMPLETED ·Phase: NA
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent
NCT01418157 ·Status: COMPLETED ·Phase: PHASE4
-
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
NCT04219982 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
NCT05886660 ·Status: RECRUITING ·Phase: PHASE2
-
The Antigagging Effect of Granisetron (Kytril), an Antiemetic Drug, in Dental Situations
NCT00502437 ·Status: UNKNOWN ·Phase: NA